EUVIMEDEUVIMED entdecken
Crossref

Engineering Asymmetric and Highly Exposed Fe Single‐Atom Nanozymes for siMMP13 Delivery and Ferroptosis Inhibition in Osteoarthritis Therapy

Ji Luo, Feiying Yin, Yuan Liang, Yuting Ye, Shihui Xiao, Jianfeng Guo, Jianhui Xiang, Guanhua Li, Xin Yang, Jiejia Deng, Junxu Yang, Zhengtian Li und 4 weitere

Advanced Materials · 2026-03 · 38 (16)

DOI: 10.1002/adma.202520951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.02.2026. Verfasst von Ji Luo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, Collaborative Innovation Centre of Regenerative Medicine and Me…. Hauptthemen laut MEDLINE: Ferroptosis, Osteoarthritis, Iron, RNA, Small Interfering. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Guangxi Scientific Research and Technological Development Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis, driven by redox imbalance, plays a critical role in osteoarthritis (OA) progression. Although antioxidant nanozymes hold therapeutic potential, designing highly efficient and targeted systems to inhibit ferroptosis remains challenging. Here, we developed a 2D nitrogen‐doped graphene‐like nanomesh (NGM) loaded with asymmetric and highly exposed Fe single atoms, carried with the cartilage‐targeting WYRGRL peptide and siRNA (siMMP13) to form Fe SAzymes (si‐FeSA/NGM‐W) as ferroptosis inhibitors to alleviate OA. By mixed molten salt and Zn removal, exfoliating Zn‐ZIF into an ultrathin 2D hierarchical porous NGM with topological defects and hierarchical structure, we created a scaffold for anchoring asymmetric and highly exposed Fe single atoms. The abundant Fe‐N 4 ‐Cl coordination active sites then introduce strain and defects, which facilitate electron transfer, enhance radical adsorption, and lower reaction barriers, thereby augmenting multi‐enzyme (SOD/CAT/GPx) activities. This enables the functionalized si‐FeSA/NGM‐W to target cartilage, where it inhibits ferroptosis by downregulating MMP13, upregulating GPX4, restoring mitochondrial function, and modulating inflammation, ultimately achieving targeted OA therapy. Mechanistically, this process involves suppression of the IL‐17 pathway and enhancement of glutathione metabolism. This work presents a targeted nanozyme platform for precise OA therapy via ferroptosis inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisOsteoarthritisIronRNA, Small InterferingOligopeptidesNanostructuresAnimalsGraphiteMiceMatrix Metalloproteinase 13

Stichwörter der Autor:innen

asymmetric and highly exposedferroptosisnanozymesosteoarthritissiMMP13

Substanzen

IronRNA, Small InterferingGraphiteOligopeptidesMatrix Metalloproteinase 13

Autor:innen und Institutionen

  • Guangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, Collaborative Innovation Centre of Regenerative Medicine and Medical Bioresource Development and Application Co-Constructed by the Pr…
  • Department of Orthopaedics Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, China.
  • State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.

ORCID-Profile: Kelong Fan

Förderung

  • Guangxi Scientific Research and Technological Development Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Luo, J., Yin, F., Liang, Y., Ye, Y., Xiao, S., Guo, J., Xiang, J., Li, G., Yang, X., Deng, J., Yang, J., Li, Z., Zhao, J., Zheng, L., Fan, K., & Zhong, J. (2026). Engineering Asymmetric and Highly Exposed Fe Single‐Atom Nanozymes for siMMP13 Delivery and Ferroptosis Inhibition in Osteoarthritis Therapy. Advanced Materials, 38(16). https://doi.org/10.1002/adma.202520951

Vancouver

Luo J, Yin F, Liang Y, Ye Y, Xiao S, Guo J, et al. Engineering Asymmetric and Highly Exposed Fe Single‐Atom Nanozymes for siMMP13 Delivery and Ferroptosis Inhibition in Osteoarthritis Therapy. Advanced Materials. 2026;38(16). doi:10.1002/adma.202520951

BibTeX
@article{Luo2026,
  author = {Luo, Ji and Yin, Feiying and Liang, Yuan and Ye, Yuting and Xiao, Shihui and Guo, Jianfeng and Xiang, Jianhui and Li, Guanhua and Yang, Xin and Deng, Jiejia and Yang, Junxu and Li, Zhengtian and Zhao, Jinmin and Zheng, Li and Fan, Kelong and Zhong, Jingping},
  title = {Engineering Asymmetric and Highly Exposed Fe Single‐Atom Nanozymes for siMMP13 Delivery and Ferroptosis Inhibition in Osteoarthritis Therapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {16},
  doi = {10.1002/adma.202520951}
}
Kostenlos starten →